Announcement
CompanyGoldmanSachs International
TIDMTTP
HeadlineEMM Disclosure
Released11:13 21 Feb 2003
Number7997H
RNS Number:7997H
GoldmanSachs International
21 February 2003
EMM DISCLOSURE
FORM 38.5 (SUMMARY)
Lodge with a RIS and the Takeover Panel. Use a separate form for each class
of securities in which dealings have been made.
CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM
Goldman Sachs International
Date of disclosure
21 February 2003
Contact name
Peter Highton
Telephone number
+44 207-774-1935
Please see attached disclosure of dealings under Rule 38.5 in the securities
of the following companies:
Cambridge Antibody Technology Group plc
Oxford Glycosciences plc
Celltech Group plc
AMENDMENT
If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:
In the case of option business or dealings in derivatives full details should
be given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date),
the exercise price and any option money paid or received. For derivatives
this should include, at least, the number of reference securities to which
they relate (when relevant), the maturity date (or if applicable the closing
out date) and the reference price.
For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638
0129. Email: monitoring@disclosure.org.uk
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Celltech Group plc
Class of security
Ordinary Shares
Date of disclosure
21 February 2003
Date of dealing
20 February 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
167,728
Highest price paid*
3.4901 GBP Sterling
Lowest price paid*
3.4720 GBP Sterling
Total number of securities sold
18,100
Highest price received*
3.5000 GBP Sterling
Lowest price received*
3.5000 GBP Sterling
*Currency must be stated
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Cambridge Antibody Technology Group plc
Class of security
Ordinary Shares
Date of disclosure
21 February 2003
Date of dealing
20 February 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
22,200
Highest price paid*
4.3700 GBP Sterling
Lowest price paid*
4.3116 GBP Sterling
Total number of securities sold
3,875
Highest price received*
4.3126 GBP Sterling
Lowest price received*
4.3126 GBP Sterling
*Currency must be stated
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Oxford Glycoscience plc
Class of security
Ordinary Shares
Date of disclosure
21 February 2003
Date of dealing
20 February 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
0
Highest price paid*
0.00 GBP Sterling
Lowest price paid*
0.00 GBP Sterling
Total number of securities sold
50,000
Highest price received*
1.9000 GBP Sterling
Lowest price received*
1.9000 GBP Sterling
*Currency must be stated